In a first, FDA approves fast-acting postpartum depression pill salon.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from salon.com Daily Mail and Mail on Sunday newspapers.
The FDA approval of zuranolone marks “a very important step forward” for the field of maternal mental health, Dr. Samantha Meltzer-Brody, director of the Center for Women’s Mood Disorders at the University of North Carolina at Chapel Hill, said in an email. She was one of the investigators on the zuranolone clinical trials.
The US Food and Drug Administration has approved the medication zuranolone for the treatment of major depressive disorder and severe postpartum depression – making it the first FDA-approved oral pill in the United States specifically for postpartum depression, a serious mental illness that can develop in about 1 in 7 new mothers after childbirth.
(CNN) The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression – making it the first FDA-approved oral pill in<a class="excerpt-read-more" href="https://wsvn.com/news/us-world/fda-approves-first-postpartum-depression-pill-in-the-us/">Read More</a>